HDAC6 inhibitors sensitize resistant t(11;14) multiple myeloma cells to a combination of bortezomib and BH3 mimetics

Affiliations

Cristina Florean: Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Luxembourg
Manon Lernoux: Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Luxembourg
Anne Lorant: Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Luxembourg
Helene Losson: Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Luxembourg
Guy Bormans: Laboratory for Radiopharmaceutical Research, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven
Michael Schnekenburger: Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Luxembourg
Marc Diederich: Research Institute of Pharmaceutical Sciences and Natural Products Research Institute, College of Pharmacy, Seoul National University, Seoul

Abstract

Not available.

ISSN: 0390-6078 (Print); 1592-8721 (Online)
Publisher: Ferrata Storti Foundation
Country of publisher: Italy
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
Website: http://www.haematologica.org